0 item $0.00

Professor Xiaowei Wang

PhD, Monash University | FAHA | FCSANZ | FESC

Professor Xiaowei Wang

Head
Molecular Imaging and Nanotherapeutics
 

Co-Lead
Heart Attack Program
 

Co-Lead
Centre for Cardiometabolic mRNA Therapy
 

 

Honorary Associate Professor (Principal Fellow), University of Melbourne

Adjunct Associate Professor and Discipline Lead, La Trobe University supervisor

Adjunct Associate Professor, Monash University

Swinburne University Supervisor

Torrens University supervisor

National Heart Foundation Future Leader Fellow

+61 3 8532 1495

Professor Xiaowei Wang heads the Molecular Imaging and Nanotherapeutics laboratory at the Baker Heart and Diabetes Institute, co-leads the Heart Attack Program, and co-leads the Centre for Cardiometabolic mRNA Therapy.

With a career that bridges clinical practice and cutting-edge research, Professor Wang began as a cardiac technologist before moving into medical research. This foundation in patient care has shaped her strong focus on translational science, bringing laboratory discoveries into real-world applications that improve diagnosis, treatment, and prevention of cardiovascular disease.

Professor Wang’s multidisciplinary research spans physics, chemistry, biology, and biotechnology, integrating basic science with the development of clinical-ready diagnostic and therapeutic solutions. She specialises in preclinical molecular imaging across multiple advanced platforms, including MRI, ultrasound, PET, microCT, fluorescence, and photoacoustic imaging. These technologies are applied for both early and accurate diagnosis, as well as in theranostic applications, where diagnosis, targeted therapy, and real-time monitoring of treatment efficacy occur in tandem.

A major focus of her work is the development of targeted drug and mRNA delivery systems using micro- and nano-particles. This includes mRNA therapeutics and vaccines for cardiovascular disease, designed to replace missing proteins, prevent heart attacks and strokes, and reduce harmful inflammation, all delivered through precision-engineered nanoparticles that minimise side effects.

Professor Wang’s contributions have been recognised with 14 Young Investigator Awards, 18 research prizes, and 27 national and international travel grants. She is a founding member of the Australian Society of Molecular Imaging (ASMI), serving as its President from 2017 to 2021. She is the current Immediate Past President of the Federation of Asian Societies of Molecular Imaging (FASMI) and the Australian Representative to both FASMI and the World Molecular Imaging Society (WMIS).

Beyond her research leadership, Professor Wang is committed to equity, mentorship, and community building in science. She is a member of the Baker Institute’s Gender Equity and Diversity Committee, Chair of the Institute’s Mentoring Committee, and serves on the Leadership Committee of the Women in Molecular Imaging Network.

Achievements

  • Australia Academy of Science 2025 France and Europe EMCR Mobility Grants, Rod Rickards Fellowship
  • Immediate Past President of the Federation of Asian Societies of Molecular Imaging
  • National Heart Foundation Future Leader Fellowship Level 2
  • Baker Institute Sir Laurence Muir Prize for Outstanding Medical Research

Award

  • World Molecular Imaging Society Mid Career Award for outstanding research and contribution
  • Inaugural Fellow of the Australian Society of Molecular Imaging
  • National Heart Foundation Paul Korner Innovation Award
  • Inaugural Women of Colour in STEM Award, finalist
  • 40 Under 40 Most Influential Asian-Australian Award
  • AVBS Achievement and Career Development Award

Publication highlights

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more